Linda F. Powers J.D. Chairperson, Chief Executive Officer, President, Chief Financial Officer and Principal Accounting Officer, Northwest Biotherapeutics, Inc.
Board Members Memberships* Director Pepgen Corporation
Director Reactive NanoTechnologies, Inc.
Member of Board of Trustees Trudeau Institute, Inc.
Director Moffitt Genetics Corporation, Inc.
2007-Present Chairperson, Chief Executive Officer, President, Chief Financial Officer and Principal Accounting Officer Northwest Biotherapeutics, Inc.
2011-Present Director Q Therapeutics, Inc.
2011-N/A Director Grace 2, Inc.
Education* BA Princeton University
JD Harvard Law School
BA Woodrow Wilson School of Public and International Affairs
Other Affiliations* Toucan Capital Corp. Pepgen Corporation Reactive NanoTechnologies, Inc. Toucan Capital Fund II, L.P. Princeton University Harvard Law School Woodrow Wilson School of Public and International Affairs Q Therapeutics, Inc. Grace 2, Inc. Trudeau Institute, Inc. Moffitt Genetics Corporation, Inc. Northwest Biotherapeutics, Gmbh
Background* Ms. Linda F. Powers, J.D., has been Chief Executive Officer of Northwest Biotherapeutics, Inc. since June 08, 2011 and serves as its President, Principal Accounting Officer and Chief Financial Officer. Ms. Powers serves as Managing Director of Toucan Capital Corp. and Toucan Capital Fund II, L.P. She is a Co-Founder of Toucan Capital Corp. and Toucan Capital Fund II, L.P. She has more than 25 years of experience in the fields of venture capital, public-private partnerships, corporate finance and restructurings, mergers and acquisitions, joint ventures, IP licensing and highly leveraged, structured, and specialty finance transactions and more than six years of experience in seed and early stage venture capital investing. Prior to Toucan Capital, she served as Senior Vice President of Global Finance at Enron Corp. Prior to joining Enron, she served as a Deputy Assistant Secretary of Commerce in the Bush Administration from 1989 to 1993. In that capacity, she was responsible for a number of small business programs, mainly concerned with access to capital. She also assisted financial services, information services, and related businesses in entering foreign markets and was responsible for government to government negotiations to remove foreign market entry restrictions for U.S. firms. In addition, Ms. Powers served as a co-lead negotiator for United States on the North American Free Trade Agreement and financial sector agreement, which opened banking, securities, insurance, pension fund, and related opportunities in Canada and Mexico. During 1980’s, she practiced law, specializing in corporate mergers, acquisitions, and financings and certain kinds of intellectual property transactions. While working for the headquarters of the European Union in Brussels, she was responsible for drafting the initial intellectual property rules, which now govern know how licensing in the European Union. Ms. Powers has been the Chairperson and Director of Northwest Biotherapeutics, Inc. since May 17, 2007. She has been a Director of Q Holdings, Inc. (formerly Grace 2, Inc.) since October 13, 2011. Ms. Powers serves as a Director of Q Therapeutics, Inc. She serves as a Director of Pepgen Corporation and Moffitt Genetics Corporation, Inc. She served as a Director of Reactive NanoTechnologies, Inc. She serves as a Trustee of Trudeau Institute, Inc. She serves on the Steering Committee at the National Academy of Sciences, evaluating Federal grant programs and on the Advisory Board at the U.S. Department of Commerce NIST Advanced Technology Program. She has served for several years on the Technology Advisory Board of the Moffitt Cancer Center in Tampa. Ms. Powers also served on the Investment Board of Maryland's state-run seed and early stage venture capital fund. Over seven years, she has become a recognized leader in the stem cell industry nationwide in the United States, as well as in Europe, India and China and has served as the Chair of Maryland's Stem Cell Commission, where she was responsible for administering the state's stem cell research funding for the first two years of the program. She has been appointed to key technology and industry commissions by the Governors of two states. Her board service includes various public boards including the Virginia Research and Technology Advisory Committee, the Advisory Board of the U.S. National Institutes of Standards and Technology's Advanced Technology Program. Ms. Powers served on the Maryland Governor's Commission on the Development of Advanced Technology Businesses, and Maryland's Enterprise Investment Fund. She co-teaches a course on Entrepreneurship for Scientists at the National Institute of Health for six years and has taught International Business Transactions and European Business Law as an Adjunct Professor at Georgetown Law School for eight years. Ms. Powers received a J.D. degree, magna cum laude, from Harvard Law School. She holds a B.A. in Economics from Woodrow Wilson School, Princeton University, where Ms. Powers graduated magna cum laude and Phi Beta Kappa.
